GlaxoSmitKline's headquarters

Revenue slump for GSK as Avandia sales stall

October 22, 2010
Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results

GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …

Pfizer recalls Lipitor tablets because of ‘musty’ smell

October 22, 2010
Manufacturing and Production Lipitor, Pfizer, pharma recalls, product recalls

Pfizer has recalled 191,000 bottles of its cholesterol drug Lipitor in the US after customers complained of an unusual, musty …

Lilly suspends late-stage trials of diabetes drug Protege

October 22, 2010
Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes

Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …

Anna Protopapas to lead Takeda’s global business development unit

October 21, 2010
Sales and Marketing Anna Protopapas, Japanese pharma company, Takeda, appointment, sales and marketing

Takeda has set up a new global business development unit within its US subsidiary to oversee mergers, acquisitions and other …

Chancellor George Osborne

NHS budget ‘will have to stretch further’

October 21, 2010
George Osborne, NHS, NHS Confederation, NHS funding, government, king's fund

The NHS budget has been protected from the worst of the Comprehensive Spending Review’s swingeing cuts, with a raise that …

Johnson & Johnson Tylenol

Johnson & Johnson recalls more Tylenol

October 21, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls

Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …

Pfizer extends portfolio with Brazilian generics deal

October 21, 2010
Brazil, IMS Health, Pfizer, em, emerging pharma marketings

Pfizer is partnering with leading Brazilian generics firm Laboratorio Teuto Brasileiro to develop and commercialise a number of generic products …

Novartis posts strong Q3 results

October 21, 2010
Sales and Marketing 2010 financials, Novartis, Novartis quarterly results, Q3, pharma sales

Novartis has posted double digit growth for the third quarter following a strong showing by a number of recently launched …

Staff blockade Sanofi-Aventis facility in France

October 21, 2010
Manufacturing and Production France, Sanofi, Sanofi-Aventis, job cuts, manufacturing and production

Workers at a Sanofi-Aventis manufacturing facility in Romainville, France, sealed off the gates of the plant to protest plans to …

European medicines legislation and pharmacovigilance

October 20, 2010
Research and Development NDA, pharmacovigilance, regulatory affairs

During the past decade, changes in European medicines legislation and guidelines have increased the scope and regulatory scrutiny of pharmacovigilance …

UK science in line for £500m boost from EU

October 20, 2010
Research and Development UK Biobank, UKCMRI, biotech funding, life sciences, science parks

The European Investment Bank has unveiled a £500 million package of loans to boost the UK’s science and education base …

FDA approves Boehringer’s Pradaxa

October 20, 2010
Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

Boehringer Ingelheim’s Pradaxa has stolen a march over its rivals by being the first new oral anticoagulant to reach the …

FDA warns of bisphosphonates fracture risk

October 20, 2010
Sales and Marketing Boniva, Fosamax, Reclast, actonel, bisphosphonates, osteoporosis

The FDA has ordered a label change for a number of osteoporosis drugs after concerns their long-term use raises the …

Pharma association the ABPI

NICE needs narrower focus, says ABPI

October 20, 2010
Sales and Marketing ABPI, NICE, value

NICE’s remit should be changed to give it a greater focus on the value of innovation, according to UK pharma …

King’s Fund appoints Kaye Lobley to leadership post

October 20, 2010
UK, appointment, king's fund

Kate Lobley will take up the post of director of leadership at health think tank The King’s Fund on 1 …

Apixaban trial for ACS abandoned

October 20, 2010
Sales and Marketing ACS, BMS, Pfizer, apixaban

  Pfizer and Bristol-Myers Squibb have halted a trial of their heart drug apixaban after signs of increased risk of …

DH Information Revolution

Digital Pharma: NHS to lead an ‘information revolution’

October 19, 2010
Medical Communications Digital Pharma blog, electronic patient records, patient information

Patients could soon be able to contact their doctor online as part of government plans for an ‘information revolution’ in …

Hill & Knowlton appoints Damaris Anderson-Supple

October 19, 2010
Medical Communications Hill & Knowlton, appointment, medical communications

PR agency Hill & Knowlton has appointed Damaris Anderson-Supple to the newly created position of chief operating officer for its …

Reaxa spins out specialist antibody-drug conjugate unit

October 19, 2010
Manufacturing and Production Mylotarg, Reaxa, antibody-drug conjugates

UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …

NHS Confederation warns on health cuts

October 19, 2010
NHS, NHS Confederation, government

In the week of the Comprehensive Spending Review, the NHS Confederation has painted a dire picture of the effect of …

The Gateway to Local Adoption Series

Latest content